1. Home
  2. OPTT vs IFRX Comparison

OPTT vs IFRX Comparison

Compare OPTT & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ocean Power Technologies Inc.

OPTT

Ocean Power Technologies Inc.

HOLD

Current Price

$0.34

Market Cap

76.0M

Sector

Utilities

ML Signal

HOLD

Logo InflaRx N.V.

IFRX

InflaRx N.V.

HOLD

Current Price

$1.10

Market Cap

71.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPTT
IFRX
Founded
1984
2007
Country
United States
Germany
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.0M
71.1M
IPO Year
2007
2017

Fundamental Metrics

Financial Performance
Metric
OPTT
IFRX
Price
$0.34
$1.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$1.50
$8.50
AVG Volume (30 Days)
3.7M
736.4K
Earning Date
12-15-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,748,000.00
$73,729.00
Revenue This Year
$70.98
N/A
Revenue Next Year
$106.21
$1,054.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.30
$0.71
52 Week High
$1.75
$2.77

Technical Indicators

Market Signals
Indicator
OPTT
IFRX
Relative Strength Index (RSI) 39.77 48.92
Support Level $0.30 $1.07
Resistance Level $0.38 $1.16
Average True Range (ATR) 0.03 0.07
MACD -0.00 0.02
Stochastic Oscillator 27.61 75.52

Price Performance

Historical Comparison
OPTT
IFRX

About OPTT Ocean Power Technologies Inc.

Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

Share on Social Networks: